Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Rebetol combination therapy recommended for approval in E.U.

March 2, 1999

Botulinum toxin compared to pneumatic dilatation in patients with achalasia

March 1, 1999

Positive ribavirin study results reported in the Journal of Hepatology

March 1, 1999

InKine schedules pre-NDA meeting with FDA for INKP-100

Feb. 26, 1999

Eradication of H. pylori may prevent long-term NSAID-related ulcers

Feb. 26, 1999

Healing of severe esophagitis linked to improvement in peristaltic dysfunction

Feb. 25, 1999

Axcan and Labopharm to develop controlled-release trimebutine formulation

Feb. 25, 1999

Ribozyme issued U.S. patent for ribozyme HCV therapeutics

Feb. 23, 1999

Janssen patents structurally distinct gastric prokinetic agents

Feb. 22, 1999

Polyol anti-Helicobacter pylori agents, compositions and use claimed by Takeda

Feb. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...